- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.07. | Vivos Therapeutics, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| VIVOS THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 30.06. | Vivos Therapeutics, Inc: Vivos' Vida Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants | 1 | GlobeNewswire (USA) | ||
| 25.06. | Vivos Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 22.06. | Vivos Therapeutics, Inc: Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity | 211 | GlobeNewswire (Europe) | LITTLETON, Colo., June 22, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment... ► Artikel lesen | |
| 16.06. | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.06. | Vivos Therapeutics plans rights offering for shareholders | 3 | Investing.com | ||
| 11.06. | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering | 250 | GlobeNewswire (Europe) | LITTLETON, Colo., June 11, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment... ► Artikel lesen | |
| 10.06. | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients | 2 | GlobeNewswire (USA) | ||
| 08.06. | Vivos Therapeutics, Inc: Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026 | 2 | GlobeNewswire (USA) | ||
| 08.06. | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.06. | Vivos Therapeutics agrees to debt-to-equity exchange with lender | 2 | Investing.com | ||
| 05.06. | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing | 238 | GlobeNewswire (Europe) | LITTLETON, Colo., June 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment... ► Artikel lesen | |
| 20.05. | Vivos Therapeutics, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 20.05. | Vivos Therapeutics reports 70% revenue increase in Q1 2026 | 2 | Investing.com | ||
| 20.05. | Vivos Therapeutics GAAP EPS of -$0.52 misses by $0.07, revenue of $5.14M beats by $0.79M | 2 | Seeking Alpha | ||
| 20.05. | Vivos Therapeutics, Inc: Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update | 233 | GlobeNewswire (Europe) | Year-over-year revenue increased 70%, reflecting contribution from Vivos' acquisition of The Sleep Center of Nevada Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., May 20... ► Artikel lesen | |
| 15.05. | Vivos Therapeutics, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 2 | SEC Filings | ||
| 22.04. | Vivos Therapeutics erhält Rüge der NASDAQ wegen Nichteinhaltung der Eigenkapitalanforderung | 6 | Investing.com Deutsch | ||
| 22.04. | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.04. | H.C. Wainwright senkt Kursziel für Vivos Therapeutics auf 2,50 US-Dollar | 1 | Investing.com Deutsch |
1 2 3 Weiter >>
47 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 13,300 | -1,41 % | EQS-News: Eckert & Ziegler SE: BaFin-Prüfung betrifft Bilanzierung der Pentixapharm-Abspaltung im Konzernabschluss 2024 - möglicher Gewinn aus aufgegebenem Geschäftsbereich ohne Auswirkung auf operative Kennzahlen | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Sonstiges
BaFin-Prüfung betrifft Bilanzierung der Pentixapharm-Abspaltung im Konzernabschluss 2024 - möglicher Gewinn aus aufgegebenem... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,070 | -4,36 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden | EQS-News: SYNLAB
/ Schlagwort(e): Sonstiges
Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden
31.03.2026... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -9,84 % | NuGen Medical Devices Inc.: NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance |
Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle free drug delivery, today announced the filing of a new... ► Artikel lesen | |
| PLUS THERAPEUTICS | 3,225 | -0,77 % | Plus Therapeutics Inc.: Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide Cerebrospinal Fluid Assay for Metastatic CNS Cancer | HOUSTON, July 21, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), announced today that it has signed... ► Artikel lesen | |
| CARDINAL HEALTH | 199,85 | -0,32 % | Cardinal Health To Buy AdaptHealth's Diabetes Unit, Strive Medical For $360 Mln Total | WASHINGTON (dpa-AFX) - Healthcare services company Cardinal Health, Inc. (CAH) announced late Monday its agreement to acquire the Diabetes Health business of AdaptHealth Corp. (AHCO), as well... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,080 | +2,97 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds | $4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrants
SEATTLE, June 12, 2026 /PRNewswire/... ► Artikel lesen | |
| INVITAE | - | - | Patentstreit: Natera sichert sich 30 % Lizenzgebühr von Invitae | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn Wound Irrigation Solution | BOULDER, CO / ACCESS Newswire / June 30, 2026 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced it has received a new 510(k)... ► Artikel lesen | |
| FRESENIUS | 43,800 | +2,22 % | ROUNDUP/Aktien Frankfurt Eröffnung: Dax moderat im Plus nach jüngsten Verlusten | FRANKFURT (dpa-AFX) - Der Dax hat sich am Montag nach zwei Verlustwochen in Folge zunächst stabilisiert. Der deutsche Leitindex schwankte im frühen Handel um seinen Schlusskurs vom Freitag und legte... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 35,060 | +3,03 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 43,270 | +0,65 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,430 | 0,00 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 72,91 | -0,01 % | BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy? |
Das Unternehmen VIVOS THERAPEUTICS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +1,73 % bei einem Aktienkurs von 0,400 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VIVOS THERAPEUTICS INC finden Sie auf Wallstreet Online.